Skip to main content

Table 2 Frequency distribution of domains and tracer items readiness indicators as well as posterior inclusion probabilities of general and malaria-specific tracers estimated from the Bayesian variable selection. Tracers with inclusion probabilities higher than 50% were selected for the MCA

From: Constructing a malaria-related health service readiness index and assessing its association with child malaria mortality: an analysis of the Burkina Faso 2014 SARA data

Domain/tracer items Medical centres (n = 112) Peripheral health centres (n = 546)
Availability (%) Posterior inclusion probability2 (%) Availability (%) Posterior inclusion probability (%)
General service
 Basic amenities1 39 (34.8)   6 (1.1)  
  Power (electric or solar device) 86 (76.8) 8.5 362 (66.3) 21.4
  Improved water source inside or within the ground of the facility 110 (98.2) 3 476 (87.2) 60.9
  Room with auditory and visual privacy for patient consultations 81 (72.3) 100 284 (52.0) 39.2
  Access to adequate sanitation facilities for clients 109 (97.3) 519 (95.1)
  Communication equipment (phone or SW radio) 111 (99.1) 535 (98.0)
  Facility has access to computer with E-mail/Internet access 56 (50.0) 6.9 10 (1.8)
  Emergency transportation 106 (94.6) 61.7 515 (94.3) 88.0
 Basic equipment 72 (64.2)   264 (48.4)  
  Adult scale 108 (96.4) 527 (96.5)
  Child scale 82 (73.2) 13.2 428 (78.4) 15.1
  Thermometer 112 (100) 544 (99.6)
  Stethoscope 112 (100) 540 (98.9)
  Blood pressure apparatus 109 (97.3) 533 (97.6)
  Light source 92 (82.1) 100 349 (63.9) 16.2
 Standard precautions for infection prevention 52 (46.4)   223 (40.8)  
  Safe final disposal of sharp materials 85 (75.9) 84.7 422 (77.3) 28.2
  Safe final disposal of infectious wastes 82 (73.2) 62.9 336 (61.5) 18.2
  Appropriate storage of sharp waste 110 (98.2) 535 (98.0)
  Appropriate storage of infectious waste 103 (92.0) 85.3 494 (90.5) 50.8
  Disinfectant 111 (99.1) 544 (99.6)
  Single use (standard disposable or auto-disable syringes) 111 (99.1) 543 (99.5)
  Soap and running water or alcohol based hand rub 105 (93.8) 33.6 518 (94.9) 99.2
  Latex gloves 100 (89.9) 56.1 499 (91.4) 99.3
  Guidelines for standard precautions 98 (87.5) 98.3 469 (85.9) 21.2
 Diagnostic capacity 37 (33.0)   3 (0.6)  
  Haemoglobin 72 (64.3) 100 9 (1.7)
  Blood glucose 50 (44.6) 48.2 6 (1.1)
  Malaria diagnostic capacity 101 (90.2) 17.5 467 (85.5) 21.3
  Urine dipstick-protein 103 (92.0) 49.0 501 (91.8) 50.1
  Urine dipstick-glucose 104 (92.9) 80.6 491 (89.9) 31.4
  HIV diagnostic capacity 106 (94.6) 32.9 512 (93.8) 39.8
  Urine test for pregnancy 96 (85.7) 26.0 412 (75.5) 42.3
 Essential medicines 2 (0.1)   0 (0)  
  Amoxicillin tablet 101 (90.2) 40.6 523 (95.8)
  Ampicillin for inject 104 (92.9) 21.7 519 (95.1)
  Gentamicin injectable 101 (90.2) 77.7 472 (86.5) 30.3
  Oxytocin injectable 98 (87.5) 100 502 (91.9) 77.8
  Amoxicillin dispersible 94 (83.9) 10.6 475 (87.0) 20.1
  Oral rehydration solution (ORS) 95 (84.8) 16.8 476 (87.2) 20.3
  Zinc 77 (68.8) 100 418 (76.6) 14.9
  Aspirin 94 (83.9) 100 377 (69.1) 19.6
  Magnesium sulfate 78 (69.6) 100 121 (22.2) 20.9
  Amlodipine 25 (22.3) 100 12 (2.2)
  Enalapril 20 (17.9) 26.1 6 (1.1)
  Insulin injectable 8 (7.1) 35.9 5 (0.9)
  Betablockers 20 (17.9) 100 8 (1.5)
  Beclomethasone inhaler 14 (12.5) 100 9 (1.7)
  Ceftriaxone injection 103 (92.0) 93.8 492 (90.1) 58.4
  Thiazidic 25 (22.3) 14.2 41 (7.5) 50.6
  Glibenclamide tablet 39 (34.8) 100 10 (1.8)
  Metformin 41 (36.6) 22.9 9 (1.7)
  Omeprazole 65 (58.0) 10.1 110 (20.2) 20.2
  Salbutamol inhaler 86 (76.8) 63.3 288 (52.8) 24.9
  Carbamazepine 28 (25.0) 69.9 0 (0.0)
  Haloperidol 27 (24.1) 96.6 0 (0.0)
  Simvastatin 4 (3.6)   
  Fluoxetin 3 (2.7)  
Malaria-specific service
 Staff and guidelines 41 (45.5)   313 (57.7)  
  Guidelines for diagnosis and treatment of malaria 105 (93.8) 22.4 536 (98.2)
  Guidelines for intermittent preventive treatment 75 (67.0) 13.0 481 (88.1) 31.1
  Staff trained in malaria diagnosis and treatment 79 (70.5) 97.5 453 (83.0) 40.9
  Staff trained in intermittent preventive treatment 74 (66.1) 100 370 (67.8) 58.9
Diagnostics 101 (90.2)   467 (85.5)  
  Malaria diagnostic capacity (rapid diagnostic test/thin blood film) 101 (90.2) 17.5 467 (85.5) 21.3
 Medicines and commodities 21 (18.8)   172 (31.5)  
  First-line antimalarial in stock (artemether+lumefantrine, artesunate+amodiaqune) 99 (88.4) 58.8 526 (96.3)
  Paracetamol cap/tab 104 (92.9) 100 418 (76.2) 34.6
  Intermittent preventive treatment of malaria in pregnancy (IPTp) drug (sulfadoxine pyrimethamine) 62 (55.4) 28.4 356 (65.2) 17.1
  ITNs 29 (25.9) 73.2 185 (33.9) 26.2
  1. 1Domain readiness indicators were defined as availability of all tracer items belonging to the domain
  2. 2Posterior inclusion probability: gives the probability of the tracer to be included in the final model and it is calculated by the proportion of all possible models in the variable selection procedure that include the specific tracer. For example, the posterior inclusion probability of 21.4 estimated for the power tracer indicates that this tracer was included in 21.4% of all possible models generated from all general services-related tracers
  3. 3Item not included in the variable selection procedure due to low relative frequency i.e. < 5%